John is a graduate of the University of Nebraska, College of Pharmacy in Omaha, Nebraska where he earned his Bachelor of Science and Doctor of Pharmacy degrees.
Prior to becoming a founding partner of RJM Group, John’s experience in healthcare includes positions as a Clinical Pharmacist at the University of Chicago Hospitals and Clinics in Chicago, Illinois, Clinical Pharmacy Coordinator and Assistant Director of Clinical Services at Cook County Hospital in Chicago, Illinois, and Director of Pharmacy and Central Supply at St. Anthony Medical Center, Crown Point, Indiana. While employed at Cook County, he was an adjunct Assistant Professor in the Department of Pharmacy Practice at the University of Illinois. After leaving the institutional practice environment, he provided consultant pharmacist services for 11 years for patients residing in Long-Term Care facilities.
His clinical practice experience focused on infectious disease, surgery and trauma. In all of his practice locations, he was responsible for the initiation of and ongoing management of clinical pharmacy services. He served as a member of the advisory board for a pharmaceutical buying group and secretary of pharmacy and therapeutics committees in institutions where he was employed.
He has lectured and published both nationally and internationally on topics including disease management, drug utilization, management of infections in the elderly, pharmacoeconomics and outcomes research.
He is a member of the American Society of Health-System Pharmacists, the Indiana Pharmacists Alliance and the Illinois Council of Health-System Pharmacists.
Gary is a graduate of the University of Pittsburgh, School of Pharmacy. He completed post-graduate training at the University of Virginia, School of Medicine in Nosocomial Infections and Hospital Epidemiology. He was Associate Director of Clinical Pharmacy Services at The INOVA Health System, Falls Church, Virginia.
Gary has been a consultant to the Medical Review Organization of Virginia, Health and Human Services (HHS) and a volunteer to the House of Representatives of the United States, specifically for the office of Fortney (Pete) Stark (D-Ca). He has held faculty appointments at the Medical College of Virginia and University of Kentucky Schools of Pharmacy.
He has also been a consultant and lecturer internationally to health policy decision-makers in the United Kingdom, People’s Republic of China, Japan, Australia and Italy. He has published papers on pharmacoeconomics and outcomes research in the United States as well as in Europe and Asia.
Memorial of Our Past Partner
Dr. Ronald J Moleski peacefully passed away February 5, 2012 in CT Hospice, Branford. Ron was a long time innovator in the field of outcomes research and evidence-based medicine. Ron taught and lectured nationally and internationally on outcomes research since the mid 80?s and contributed to the development of what is now comparative effectiveness research and evidence-based medicine.
Ron was a graduate of UCONN Pharmacy School and earned his Clinical Doctorate from the Philadelphia School of Pharmacy and Science. He held positions as Director of Pharmacy at Danbury Hospital, Associate Director of Clinical Services at the Hospital of Saint Raphael in New Haven, CT and Director of Drug Information and Clinical Services at Yale-New Haven Hospital, also in New Haven, CT. He also held a full-time faculty position at the University of Rhode Island College of Pharmacy. He was President of the Connecticut Society of Hospital Pharmacists in 1985. After leaving St. Raphael in 1995, Ron started his own company, RJM Marketing and Research Associates. In 2000, he joined with 2 other business partners to form RJM Group LLC. He was active in that capacity until his passing.
Ron’s areas of interest and expertise included: infectious diseases, hematology and oncology, and pain management. He was instrumental in developing the patient-controlled analgesia program at Yale-New Haven Hospital and developed the Pain Management Program at the Hospital of Saint Raphael. He is well published in the infectious disease, oncology, anesthesiology and clinical pharmacy literature. As a partner in RJM Group LLC, Ron took his interest and skills and translated them into the performance of studies to quantify and evaluate drug and device impact on patients, care givers, providers and health systems.